Quarterly report pursuant to Section 13 or 15(d)

Shareholders Equity (Unaudited)

v3.10.0.1
Shareholders Equity (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
Common stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Non-controlling Interest
Total
Beginning Balance, Amount at Dec. 31, 2017 $ 27,357 $ 25,185,487 $ (249,265) $ (13,989,018) $ 510,782 $ 11,485,343
Beginning Balance, Shares at Dec. 31, 2017 27,356,838   189,020      
Common stock previously issued and canceled, Amount $ (72) (67,929)       (68,001)
Common stock previously issued and canceled, Shares (71,667)          
Common stock issued for services rendered, Amount $ 156 195,219       $ 195,375
Common stock issued for services rendered, Shares 156,338         156,338
Common stock previously issued returned to treasury and canceled, Amount $ (189) (249,076) $ 249,265      
Common stock previously issued returned to treasury and canceled, Shares (189,020)   (189,020)      
Sale of common sock, Amount $ 5,000 7,495,000       $ 7,500,000
Sale of common sock,Shares 5,000,000          
Reclassify put option in connection to sale of common stock to temporary equity (7,500,000)       (7,500,000)
Acquisition of Crane Creek Surgery Center (129,389)     (270,611) (400,000)
Stock based compensation, Amount $ 350 501,052       $ 501,402
Stock based compensation,Shares 350,000         350,000
Net income   447,301 155,803 $ 603,104
Ending Balance, Amount at Sep. 30, 2018 $ 32,602 $ 25,430,364 $ (13,541,717) $ 395,974 $ 12,317,223
Ending Balance, Shares at Sep. 30, 2018 32,602,489